90 unknown, 63 recruiting, 30 not yet recruiting, 27 completed. 53 Not applicable, 44 Phase 2, 25 Phase 1, 20 Early Phase 1, 19 Phase 3.
Follow Anhui Provincial Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT Anti-Thymocyte Globulin (Rabbit) (Thymoglobulin®) - Aplastic Anaemia | Phase 2 | Not yet recruiting | Anhui Provincial Hospital | 59 | 2027-08-01 | 2026-10-21 |
| Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment of HER2-positive Unresectable Biliary Tract Tumors Zanidatamab - Biliary Tract Cancer | Phase 2 | Not yet recruiting | Anhui Provincial Hospital | 15 | 2026-11-30 | 2026-10-01 |
| Perioperative Adebrelimab for Locally Advanced Cervical Cancer Adebrelimab, Paclitaxel, Cisplatin - Locally Advanced Cervical Cancer | Phase 2 | Not yet recruiting | Anhui Provincial Hospital | 35 | 2026-10-01 | 2026-09-10 |
| Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma Oral elemental zinc supplementation, 20 mg/day, Oral elemental zinc supplementation, 30 mg/day, Standard-of-care targeted therapy plus immunotherapy - Hepatocellular Carcinoma | Phase 2 | Recruiting | Anhui Provincial Hospital | 60 | 2026-09-16 | 2026-09-21 |
| Spinal Cord Stimulation for Poststroke Spasticity Active spinal cord stimulation, Sham spinal cord stimulation - Spasticity Post Stroke | Not applicable | Recruiting | Beijing Pins Medical Co., Ltd | 92 | 2026-09-09 | 2026-09-21 |
| Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer Cervical Cancer, HPV DNA | Not yet recruiting | Anhui Provincial Hospital | 580 | 2026-09-01 | 2026-08-24 | |
| Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME) Mazdutide, Placebo (Normal Saline), Lifestyle Optimization - Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis | Phase 4 | Recruiting | West China Hospital | 60 | 2026-09-01 | 2026-09-23 |
| Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer Dual GIP/GLP-1 receptor agonist - Tirzepatide, Frozen Embryo Transfer | Not applicable | Not yet recruiting | RenJi Hospital | 1510 | 2026-09-01 | 2026-09-10 |
| Trial of Ultrasound-guided Rotation for Normalizing Head Position Trial of Ultrasound-guided Rotation for Normalizing Head position, Standard Care plus Sham Ultrasound - Abnormal Fetal Head Position | Not applicable | Not yet recruiting | Anhui Provincial Hospital | 164 | 2026-08-01 | 2026-08-24 |
| Targeted Biopsy, Rapid Pathology, and Immediate Surgery in USTC High-Risk Prostate Cancer: A Prospective Multicenter Study Targeted Biopsy, Intraoperative Rapid Pathology, and Immediate Radical Prostatectomy (FROST-RP) - Prostate Cancer | Not applicable | Not yet recruiting | Anhui Provincial Hospital | 150 | 2026-08-01 | 2026-07-16 |
| Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation MegaLT Injection - Thrombocytopenia, Hematologic Malignacies | Early Phase 1 | Not yet recruiting | Anhui Provincial Hospital | 7 | 2026-07-31 | 2026-07-10 |
| Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment Intrasaccular Flow Disruption Device - Intracranial Aneurysm | Recruiting | Xuanwu Hospital, Beijing | 1000 | 2026-06-10 | 2026-06-11 | |
| Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC Centrally Confined 8 Gy/1 Fraction Immune-Priming Radiotherapy to the Tumor Core Followed by Definitive Concurrent Chemoradiotherapy - Locally-Advanced Non-Small Cell Lung Cancer, Radiotherapy | Phase 1 | Not yet recruiting | Anhui Provincial Hospital | 24 | 2026-06-01 | 2026-04-13 |
| Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab, Taxanes combined with trastuzumab and pertuzumab. - Advanced HER2-positive Breast Cancer | Phase 2 | Not yet recruiting | Fudan University | 140 | 2026-06-01 | 2026-05-12 |
| China Metastatic Liver Cancer Clinical Registry Cohort Database Standard of Care for Metastatic Liver Cancer - Liver Metastases, Metastases to Liver | Recruiting | Anhui Provincial Hospital | 2000 | 2026-06-01 | 2026-05-22 | |
| Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation Trimethoprim-Sulfamethoxazole (TMP-SMX) - Pneumocystis Jirovecii Pneumonia, Kidney Transplantation | Phase 4 | Not yet recruiting | Anhui Provincial Hospital | 1084 | 2026-06-01 | 2026-06-01 |
| Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) Recombinant Human Growth Hormone (rhGH) Injection, Standard Care (Treatment as Usual) - Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury | Phase 4 | Not yet recruiting | Anhui Provincial Hospital | 160 | 2026-04-10 | 2026-03-19 |
| Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT. Time of choosing VPS and VP - Ventriculoperitoneal Shunt (VPS), Cranioplasty | Not applicable | Not yet recruiting | Anhui Provincial Hospital | 300 | 2026-04-01 | 2026-03-10 |
| Anti CD19 Gene Therapy for B-cell Lymphoma Anti-CD19 gene injection - B-cell Lymphoma | Not applicable | Recruiting | Anhui Provincial Hospital | 18 | 2026-03-20 | 2026-01-21 |
| PregnAncy-Related Aortic DISsEction in China Intervention strategies including medication or surgery - Pregnancy Complication, Aortic Dissection | Recruiting | DeltaHealth Hospital · Shanghai | 500 | 2026-03-17 | 2026-07-17 |
Showing 20 of 225. Sign in to see all of them.
Carcinoma, Hepatocellular (17) · Prostatic Neoplasms (13) · Esophageal Squamous Cell Carcinoma (9) · Uterine Cervical Neoplasms (9) · Disease (7) · Carcinoma, Non-Small-Cell Lung (6) · Esophageal Neoplasms (6) · Leukemia, Myeloid, Acute (6) · Liver Neoplasms (6) · Colorectal Neoplasms (5) · Stomach Neoplasms (5) · Carcinoma, Ovarian Epithelial (4) · Lymphoma, Large B-Cell, Diffuse (4) · Neoplasms (4) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)
Cyclophosphamide (5) · apatinib (5) · fludarabine (5) · Bevacizumab (4) · Cisplatin (3) · Control Groups (3) · Immune Checkpoint Inhibitors (3) · Immunotherapy (3) · Immunotherapy, Adoptive (3) · Injections (3) · Sorafenib (3) · Standard of Care (3) · Antigens, CD19 (2) · Antilymphocyte Serum (2) · Azacitidine (2)
China (195)
Xiaoyu Zhu, Ph.D (7) · Ying Zhou, MD (6) · Xiaoyu Zhu, ph.D (5) · Xingbing Wang (5) · Shao Feng, MD (4) · Lianxin Liu (3) · Qiang Xie (3) · Hao Xu (2) · Jian Zhou (2) · Ming Hou, DR. (2) · Qiang Xie, MD (2) · Tao Tao, MD Ph.D (2) · Xiaoyu Zhu, MD (2) · Yan Sun, MD (2)
PMID 10207464, PMID 12049862, PMID 12594571, PMID 12623635, PMID 12893895, PMID 16305946, PMID 17877488, PMID 18355796, PMID 18615186, PMID 18650514, PMID 18852074, PMID 19036778, PMID 19095497, PMID 19241423, PMID 19304921, PMID 19382860, PMID 19453695, PMID 19560026, PMID 19926229, PMID 20175033, PMID 20576472, PMID 21374666, PMID 21966941, PMID 22173160, PMID 22190656, PMID 22353262, PMID 22405632, PMID 22424278, PMID 22544225, PMID 22766484, PMID 23216261, PMID 23399463, PMID 23482806, PMID 23641043, PMID 23670100, PMID 23932377, PMID 24410841, PMID 24872377, PMID 24935203, PMID 24937670, PMID 25139639, PMID 25370155, PMID 25440593, PMID 25516662, PMID 25559415, PMID 25559471, PMID 25903352, PMID 25965575, PMID 26148053, PMID 26290587